Invesco Ltd: Form 8.3 - PRS REIT PLC/The; Public dealing Disclosure
November 07, 2024 07:18 ET
|
Invesco Ltd.
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of...
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
November 07, 2024 07:15 ET
|
Invesco Ltd.
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of...
Net Asset Value(s)
November 07, 2024 07:15 ET
|
Octopus AIM VCT 2 plc
Octopus AIM VCT 2 plc Net Asset Value Octopus AIM VCT 2 plc announces that as at 31 October 2024 the unaudited net asset value of the Ordinary shares was approximately 40.4 pence per share. ...
Net Asset Value(s)
November 07, 2024 07:15 ET
|
Octopus AIM VCT PLC
Octopus AIM VCT plc Net Asset Value Octopus AIM VCT plc announces that as at 31 October 2024 the unaudited net asset value of the Ordinary shares was approximately 54.1 pence per share. ...
Draganfly to Participate in ElevateUAV, Providing Specialized Training on Advanced Drone Platforms
November 07, 2024 07:15 ET
|
Draganfly Inc
Draganfly's hands-on training at ElevateUAV underscores its commitment to empowering operators with cutting-edge skills to advance UAV applications in critical sectors. Miami, FL, Nov. 07, 2024 ...
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
November 07, 2024 07:13 ET
|
Invesco Ltd.
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of...
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
November 07, 2024 07:10 ET
|
Royalty Pharma plc
RYTELO™ (imetelstat) is FDA approved for the treatment of low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemiaTransaction increases Royalty Pharma’s synthetic...
Fluid Sensors Market Size & Share to Surpass USD 19.4 billion by 2031 | Analysis by Transparency Market Research, Inc.
November 07, 2024 07:10 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The global fluid sensors market (유체 센서 시장) is estimated to flourish at a CAGR of 9.5% from...
Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call
November 07, 2024 07:05 ET
|
Celcuity Inc.
MINNEAPOLIS, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it...
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
November 07, 2024 07:05 ET
|
Zenas BioPharma
WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the...
- November 07, 2024 07:00 ET Gate.io Launches Ola Network (OLA) Incentive Event, Offering a $20,000 Prize Pool
- November 07, 2024 07:00 ET Aya Gold & Silver Commences Processing of Ore at Zgounder